Lupin Gets Namenda License In Forest Settlement
Lupin Ltd. has received a license to begin selling a generic version of Forest Laboratories Inc.'s Namenda about four months before a patent for the lucrative Alzheimer's drug expires, as part...To view the full article, register now.
Already a subscriber? Click here to view full article